Exclusive

Publication

Byline

Alkem eyes leadership in weight-loss drugs with aggressive generic pricing

New Delhi, March 22 -- Alkem Laboratories is positioning itself to lead India's fast-growing weight-loss drug market, driven by its in-house semaglutide development, a well-trained medical representat... Read More


India's weight-loss drug rush kicks off with generics 50-90% cheaper

MUMBAI, March 21 -- A day after semaglutide lost patent protection in India, top drugmakers including Dr Reddy's, Sun Pharma, and Zydus Lifesciences launched generic versions priced 50-90% below the i... Read More


Emcure betting on innovator edge in crowded weight-loss drug market

New Delhi, March 20 -- Emcure Pharmaceuticals, which is bringing Novo Nordisk's blockbuster semaglutide to India in an exclusive partnership, is banking on the perceived superiority and brand recognit... Read More


Prices of weight-loss drugs may halve in India

Mumbai, March 20 -- India's weight-loss drug market is on the verge of a price shake-up. In days, domestic drugmakers are set to launch cheaper versions of semaglutide, the GLP-1 (glucagon-like peptid... Read More


Natco Pharma fires first shot in weight-loss drug price war; generic semaglutide to cost 90% less at Rs.1,290 per month

MUMBAI, March 20 -- Natco Pharma has heralded what could become an intense pricing war in India's pharmaceutical sector by offering its version of generic semaglutide that's 90% cheaper than the origi... Read More


Dr Reddy's, Sun, Zydus ready semaglutide generics, weight loss drug's prices expected to halve in India

New Delhi, March 19 -- India's weight-loss drug market is on the verge of a price shake-up. In days, domestic drugmakers are set to launch cheaper versions of semaglutide, the GLP-1 (glucagon-like pe... Read More